[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
October 20, 1951


JAMA. 1951;147(8):760-761. doi:10.1001/jama.1951.03670250052014

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The Second Poliomyelitis Conference of the International Poliomyelitis Congress, which was held recently in Copenhagen, Denmark, was attended by almost a thousand persons, including almost 600 physicians. Thirty-seven countries were represented, and, if one can judge from the enthusiasm shown by the delegates, as many if not more countries will be heard from when the next conference is called. The information that was exchanged was made available and was received with a degree of understanding that left no doubt concerning its value for those interested in anterior poliomyelitis.

There was no announcement of a miracle drug as a cure or of the development of measures which at this time will prevent this disease in humans, but there was revealed research that shows promise of therapeutic and preventive measures that will permit eventually as much control over this disease as has been attained for other infectious processes. For example, one researcher

First Page Preview View Large
First page PDF preview
First page PDF preview